Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Reduction of chemotherapy driven late adverse effects through targeted molecular therapies in high-risk pediatric cancers

Information

Project Team

Outputs and Outcomes

Promotor

Franki Speleman

Department of Pediatrics and medical genetics